Page 1640 - Coronavirus

Monetary policy: Here's why RBI may go for rate cut on Thursday

BofA says the RBI will not only cut rates now, but will follow it up with another 75 bps cut in rest of the financial year 2020-21 (FY21)

US to pay over $1 bn for 100 mn doses of J&J's potential Covid-19 vaccine

J&J has already received $1 billion in funding from the US

As UK eases lockdown, services activity expands at fastest pace in 5 years

IHS Markit's Purchasing Managers' Index rose to 56.5 last month, up from 47.1 in June

Financial sector firms hit market to prepare for post-Covid world

Most private banks and non-banking firms are able to raise money on the strength of their profile

DGFT undergoing an overhaul to boost trade post-Covid pandemic

Exporters have for long been demanding that the DGFT portal be made more comprehensive and its online services more interactive and customer-focused

Moratorium extension will lead to debt pile-up: Sunil Mehta, CEO, IBA

In an interview, SUNIL MEHTA discusses with Somesh Jha the demerits of extending the loan moratorium window and argues why it is the right time for the regulator to allow banks to restructure loans

Disney takes $5-bn hit but Covid-19 pandemic impact not as bad as feared

Disney's quarterly profit of 8 cents per share on an adjusted basis beat expectations for a loss of 64 cents, sending the stock up 5 per cent in after-market trade

Looking for a second home? UK, Spain among top destinations: Knight Frank

One in four people surveyed by Knight Frank said they were more likely to move in the next 12 months as a result of the Covid-19 pandemic

Malls in Mumbai resume operations after four months; rains hinder footfall

Even as torrential rains lashed the city, the malls in Mumbai witnessed 15-20 per cent footfall on Wednesday, on opening after a gap of over four months.

DLF reports Rs 180 cr loss before tax on lockdown-induced disruption

Firm's operating revenue plunged 59 per cent year-on-year to Rs 543.6 crore from Rs 1,331.2 crore

Godrej Properties seeing reasonable valuations in JVs, says chairman

Pirojsha Godrej says company will look at both organic and inorganic opportunities for growth, is bullish on medium and long-term prospects for residential real estate

Virtual war rooms set tone for mega e-commerce sale in Covid-19 times

While there's been no dinner on the house in the run up to the D-Day, the typical war room or the command centre has silently moved to the laptop and mobile screens of the executives coordinating the

Mined zinc production in India declined 5% in June quarter: Vedanta

Giving an update on its zinc production in the country, the company said the "mined metal production for Q1FY21 was 202,000 tonnes

Nifty50 valuation hits all-time high as investors bid up share prices

Index is trading at 30.4 times its trailing 12-month earnings per share, highest since it began reporting its ratios in 1999

Govt tackling Covid-19 pandemic in cooperation with people: Gehlot

Ashok Gehlot said the Rajasthan government's concerted efforts in cooperation with non-governmental organizations and people have helped the state in dealing with the challenge of coronavirus

Women likely to be harder hit than men by trade disruptions: WTO report

Women are likely to be harder hit than men by trade disruptions caused by the Covid-19 pandemic and the dangers are particularly acute in developing countries

Supreme Court suggests cheaper Covid-19 treatment in smaller towns

The apex court also asked the Centre to consider the aspect of prompt release of claims by insurance companies which cannot keep their hands off at the time of pandemic

Fast-moving story slides into the slow lane but Britannia bucks the trend

Most players struggle to get back on course, but Britannia emerges stronger

Lupin launches Covid-19 drug Favipiravir in India at Rs 49 per tablet

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use of its product

CVS raises profit forecast, in talks with US to administer Covid vaccines

CVS also said it was working with laboratories to cut down the turnaround time for coronavirus test results, which had spiked in July due to a massive increase in demand for tests